At IVRS, we understand that every step of the drug development process is critical. From initial discovery to eventual market release, it’s imperative to have a solid foundation built on comprehensive preclinical drug validation. Our team of experts specializes in guiding you through this essential phase, helping you make informed decisions that can ultimately lead to safer, more effective drugs.
We offer comprehensive safety assessments to evaluate the potential toxicity and adverse effects of your drug candidate. Our state-of-the-art facilities and experienced team conduct a range of safety studies to assess the drug’s impact on vital organs and systems.
Our experts can help you determine if your drug candidate has the desired therapeutic effects in relevant preclinical models. We provide detailed data to support your claims of efficacy and guide further development.
Understanding how your drug is absorbed, distributed, metabolized, and excreted is critical. Our PK/PD studies provide essential insights into dosing, bioavailability, and optimal treatment regimens.
We elucidate the mechanism of action of your drug, helping you understand how it interacts with specific molecular targets and pathways. This knowledge is crucial for optimizing the drug’s efficacy and safety.
We have the expertise to work with wide variety of compounds and lead drugs, such as Small Molecules, Immunotherapy, Cell Therapy, Gene Therapy, Antibiotics and Antiviral Drugs, Oncology Drugs, Anti-inflammatory Drugs, Metabolic and Cardiovascular Drugs.
At IVRS, you gain access to a team of dedicated professionals who are committed to the success of your project. We tailor our approach to your specific needs, ensuring that you have the data and insights required to make informed decisions throughout the drug development journey.
Ready to learn more about how drug validation can benefit your research? Contact our team of experts at IVRS to get started.
Do you want to learn more about our work and how we can help you?
Visit us
